IBL HealthCare Limited (PSX:IBLHL)

Market Cap	4.73B +48.7%
Revenue (ttm)	4.48B +25.7%
Net Income	240.39M
EPS	2.45
Shares Out	98.53M
PE Ratio	19.64
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	243,395
Average Volume	488,290
Open	47.60
Previous Close	47.72
Day's Range	46.29 - 48.79
52-Week Range	24.35 - 85.82
Beta	0.45
RSI	51.84
Earnings Date	Apr 28, 2026

About IBL HealthCare

IBL HealthCare Limited engages in marketing, selling, and distribution of healthcare and pharmaceutical products in Pakistan. The company offers toddler, baby cereals, infant formulas, medical, lifestyle nutrition, and specialty nutrition products; hygiene and safety products; consumer health products; and vision care and pharma products. It also provides renal care products, such as hollow fiber dialyzer, tubing sets for hemodialysis, double lumen catheter kits, and disposable AV fistula needles; critical care and anesthesia products, such as ...

• Industry: Food & Drug Retailing
• Sector: Consumer Non-Cyclicals
• Founded: 1997
• Employees: 224
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: IBLHL

Financial Performance

In fiscal year 2025, IBL HealthCare's revenue was 4.32 billion, an increase of 19.96% compared to the previous year's 3.60 billion. Earnings were 208.37 million, an increase of 2658.05%.